Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of DLC1 mRNA | affects expression | 17562736
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of DLC1 mRNA | affects expression | 16483693
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in decreased expression of DLC1 mRNA | decreases expression | 17484886
|
D003520 |
Cyclophosphamide |
Cyclophosphamide results in increased expression of DLC1 mRNA | increases expression | 17403535
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of DLC1 mRNA | decreases expression | 20106945
|
C014347 |
decitabine |
decitabine affects the methylation of DLC1 promoter | affects methylation | 17571247
|
D004317 |
Doxorubicin |
DLC1 protein affects the susceptibility to Doxorubicin | affects response to substance | 16217747
|
D004958 |
Estradiol |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of DLC1 mRNA | affects cotreatment|decreases expression | 19619570
|
D004958 |
Estradiol |
Estradiol results in increased expression of DLC1 mRNA | increases expression | 19619570
|
D005472 |
Fluorouracil |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of DLC1 mRNA] | affects reaction|decreases expression | 15016801
|
C051890 |
irinotecan |
irinotecan analog results in decreased expression of DLC1 mRNA | decreases expression | 18927307
|
C008493 |
methylselenic acid |
methylselenic acid results in increased expression of DLC1 mRNA | increases expression | 12517777
|
D015735 |
Mifepristone |
Mifepristone inhibits the reaction [Progesterone results in increased expression of DLC1 mRNA] | decreases reaction|increases expression | 15674352
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of DLC1 mRNA | affects binding|increases activity|increases expression | 19710929
|
D011374 |
Progesterone |
Mifepristone inhibits the reaction [Progesterone results in increased expression of DLC1 mRNA] | decreases reaction|increases expression | 15674352
|
D011374 |
Progesterone |
Progesterone results in increased expression of DLC1 mRNA | increases expression | 15674352
|
D013749 |
Tetrachlorodibenzodioxin |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of DLC1 mRNA | affects cotreatment|decreases expression | 19619570
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of DLC1 mRNA | decreases expression | 19619570
|
D019772 |
Topotecan |
DLC1 protein affects the susceptibility to Topotecan | affects response to substance | 16217747
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.87 | 14514962 15322242 11752688 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.58 | 18287403 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.12 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
7.17 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
7.17 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
7.17 | 17638652 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
9.97 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
9.97 | 16835633 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.55 | 21441931 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
8.69 | 16511603 15504547 17963324 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
8.69 | 11748828 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.87 | 10982225 |
MESH:D001161 |
Arteriosclerosis |
|
Cyclophosphamide |
4.61 | 15014928 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.42 | 18445737 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
8.78 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.78 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.82 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.76 | 15746008 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.73 | 14601052 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.37 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
4.27 | 15665606 15845082 15380490 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
3.81 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
Cyclophosphamide |
3.78 | 17020986 18234424 18323546 11325840 16978400 17388661 12006526 15136595 15093573 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
3.78 | 19208741 18320071 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
3.78 | 16264153 15993339 15939500 16595493 19526202 17426702 15136595 18382427 16096432 16935488 17983394 15634643 17369602 11325840 18628466 15668708 18695136 15692762 16826403 16322301 15994142 15567936 18234424 16115903 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
3.78 | 17018787 18497071 12948864 19861407 17289903 16675129 14630087 17261762 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
3.78 | 15136595 16110121 19217205 18608205 16595493 16557594 18357371 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
3.78 | 17614352 16175315 15562024 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
3.78 | 20435547 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.48 | 16111702 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.79 | 16050911 16011737 16192424 16227642 15721981 15673190 15700767 16124888 3786805 16097048 18705752 10355542 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
12.46 | 16051944 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
12.46 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
8.19 | 17121937 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
8.19 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
11.41 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
11.41 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cyclophosphamide |
11.41 | 19701751 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
11.41 | 18059187 16234567 16023760 17876044 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
11.41 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
11.41 | 18930000 17045692 16799960 17088986 17971768 16332177 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
Cyclophosphamide |
4.91 | 16152834 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Cyclophosphamide |
10.91 | 16201981 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
10.91 | 16201981 1485588 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
10.91 | 18695887 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
7.65 | 19215824 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
7.65 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
7.65 | 16757204 18986760 17066447 16280240 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.37 | 16120746 18670907 18850075 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.53 | 15792986 16242529 17382496 17131338 16455267 17007740 16612575 16109756 15811867 17519947 16278810 18627295 17924179 15476868 17974986 16364871 16952015 15505089 17928571 17308081 16651473 16269455 17351982 16731534 17329180 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.94 | 17334414 16243910 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.58 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
6.58 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
6.58 | 18566989 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.16 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
7.76 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
7.76 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.10 | 8697196 15340226 16354765 12621046 15668235 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
5.93 | 17616700 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
5.93 | 17287894 17725105 18772588 16510598 16340194 15001691 17172411 17016597 17169374 17018589 |
MESH:D003110 |
Colonic Neoplasms |
|
irinotecan |
5.93 | 17287894 17725105 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
4.84 | 18981723 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
4.84 | 18802399 18259882 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
4.84 | 16391804 15289873 18448328 18288408 17695437 17094418 16524972 17255274 16282729 14970324 17401013 18949393 16331619 17594712 18802399 17016601 15148649 16303861 17454858 18383874 20501625 18509181 |
MESH:D015179 |
Colorectal Neoplasms |
|
irinotecan |
4.84 | 17159606 17454858 16391804 18509181 18259882 15273666 16303861 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.06 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.25 | 15322242 10048152 20055451 |
MESH:D003556 |
Cystitis |
|
Cyclophosphamide |
5.02 | 18433785 17010015 16413132 18710439 12388444 16651033 18295254 16989017 12913760 10700343 10498854 11948286 18483878 12161096 15643279 15276878 18372110 16614059 17979934 18093676 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
4.81 | 16733453 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.43 | 18249437 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Cyclophosphamide |
4.07 | 10990075 15331540 11751995 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Cyclophosphamide |
3.22 | 18772604 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.67 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.41 | 19279558 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.51 | 17187935 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
8.98 | 19085960 10915739 19416960 11287661 11834606 10663392 17522070 19739265 16485898 12153990 16781746 16393943 10774834 12540782 16177239 12392966 16081117 19420014 16227642 19370779 14725611 18713872 11421492 19164858 16109766 11529661 11461765 17562736 15968718 12594235 17906064 14550746 12705907 15619225 12958197 11743745 18071297 11739529 14986274 19923254 2444490 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
8.98 | 16177239 3786805 21278145 6884620 17522070 15027814 2869522 7179309 4309450 3732212 19085960 19336974 15968718 7120509 10915739 11566570 7440962 10092053 16227642 15998439 9327722 6623471 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
8.98 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
8.98 | 20420201 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.13 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
8.12 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
8.12 | 11462148 |
MESH:D004487 |
Edema |
|
pirinixic acid |
6.55 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.55 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.93 | 18230668 16714409 15322242 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
3.79 | 17692515 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
5.15 | 19294695 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
7.55 | 17359293 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
7.55 | 19148513 11473722 18566989 |
MESH:D004715 |
Endometriosis |
|
Mifepristone |
15.36 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
15.36 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
15.36 | 10568697 9294722 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
5.19 | 18037988 |
MESH:D004802 |
Eosinophilia |
|
Cyclophosphamide |
4.23 | 11006010 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
2.45 | 16337965 17638652 16785472 16481741 15173087 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.01 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
13.08 | 12631006 61145 12795759 16045604 15959796 19224547 17595544 16239168 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
13.08 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
13.08 | 19236843 20131406 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.47 | 11858732 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.61 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
14.80 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
14.80 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
14.80 | 20067830 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.71 | 16983495 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.24 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
3.35 | 17150277 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
2.87 | 16145905 |
MESH:D018316 |
Gliosarcoma |
|
Cyclophosphamide |
5.53 | 11389073 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.62 | 10696789 |
MESH:D006086 |
Graft vs Host Disease |
|
Cyclophosphamide |
5.05 | 16376943 15172196 11014644 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
13.03 | 19215824 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
13.03 | 15692506 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
13.03 | 15102660 15162350 18337622 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.33 | 11294989 10048152 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.48 | 18674790 16879835 16244371 12587719 16330681 17888722 16707910 14766674 16244372 18006777 17875725 16144979 16495754 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
7.05 | 17481944 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
7.05 | 20558911 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.90 | 15692506 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.44 | 15720958 |
MESH:D006467 |
Hemophilia A |
|
Cyclophosphamide |
5.30 | 11918545 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.34 | 11000095 |
MESH:D006504 |
Hepatic Veno-Occlusive Disease |
|
Cyclophosphamide |
5.56 | 14986274 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
3.60 | 19900420 19110552 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
8.31 | 18467677 16221962 19772884 19176532 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
8.31 | 16120746 15340226 12621046 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
5.06 | 15709030 |
MESH:D006689 |
Hodgkin Disease |
|
Cyclophosphamide |
7.72 | 16135485 17606976 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
7.72 | 18501091 15147373 17606976 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.78 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.08 | 16959395 15340226 8697196 16354765 18606429 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.70 | 16870215 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.55 | 16899240 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.19 | 20558911 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
4.95 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
4.95 | 18670907 18850075 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
4.10 | 15338365 |
MESH:D007154 |
Immune System Diseases |
|
Cyclophosphamide |
5.36 | 16076520 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.41 | 15869954 |
MESH:D007248 |
Infertility, Male |
|
Cyclophosphamide |
7.14 | 7193160 16517039 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
7.14 | 17581917 |
MESH:D007249 |
Inflammation |
|
Progesterone |
4.98 | 15869954 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
4.98 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
7.20 | 16627594 16393666 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
7.20 | 16306350 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.34 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.47 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
14.44 | 15629191 12587719 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
14.44 | 8314463 10903974 18776723 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
14.44 | 16775033 15699352 15369732 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
14.44 | 15618244 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
4.16 | 16707910 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
12.43 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
12.43 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
12.43 | 16985049 |
MESH:D007938 |
Leukemia |
|
Cyclophosphamide |
6.70 | 10602166 |
MESH:D007938 |
Leukemia |
|
decitabine |
6.70 | 18980019 19235587 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
5.19 | 16085563 |
MESH:D015451 |
Leukemia, Lymphocytic, Chronic, B-Cell |
|
Cyclophosphamide |
3.50 | 17008537 17802794 17658394 17296974 18587576 18172266 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
Cyclophosphamide |
4.09 | 10373061 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
4.01 | 19117987 18454857 17236224 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
2.38 | 19387464 18704418 18206229 19010910 17679729 18460780 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
5.49 | 18055864 |
MESH:D007970 |
Leukopenia |
|
Cyclophosphamide |
4.99 | 11830472 10052129 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
2.81 | 17157831 17334410 16943688 16239168 11903743 11408273 16221502 21278145 17174718 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
6.73 | 15338365 14512876 15123356 12649538 18210741 12546737 12958196 12666154 15362042 18472094 15996030 15730626 18339082 15818738 17708605 18277467 17805973 18006644 12632512 18251166 17766677 16136751 17631135 12389079 16192424 12898905 16248980 12632514 18187930 18376398 17761835 14748882 18166357 17481882 12445418 18472332 15650968 17869086 18317297 17823541 15876570 18412020 18481824 17557913 11481614 16638106 12667390 14716496 17721639 18395914 20821823 17922224 16116963 14620537 15052691 15370692 16033810 15931870 12609069 17714472 18054572 15673190 10355542 15925388 18205269 17976157 14724832 18263696 18279442 17944888 18418968 17698563 16027843 12445421 14716833 18429990 17640975 17565644 17900296 16015684 15057751 18395095 16011737 18705752 16097048 12586293 17525996 15959796 15893842 13678700 12741479 18156304 18420326 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
6.73 | 16439617 16595196 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
6.73 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
6.73 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
6.73 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
3.90 | 19460945 16610002 19784758 16611625 12969438 12587719 19014921 11587558 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
3.90 | 15720792 16246199 17285989 16964402 15830285 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
4.18 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
9.42 | 16871587 17185352 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
9.42 | 14706259 16899240 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
10.69 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
10.69 | 16603448 17045692 18383874 15113037 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
10.69 | 16377806 15890375 20007298 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
10.69 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
9.86 | 12014681 15583823 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
9.86 | 17085340 16842330 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
9.86 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
3.46 | 6189445 17418594 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
3.46 | 15246190 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.46 | 11884234 19555203 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
4.81 | 15086387 |
MESH:D008223 |
Lymphoma |
|
Cyclophosphamide |
12.70 | 12854902 |
MESH:D008223 |
Lymphoma |
|
decitabine |
12.70 | 19470736 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
12.70 | 16098063 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Cyclophosphamide |
4.60 | 16675587 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Cyclophosphamide |
9.00 | 11911406 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
9.00 | 17654614 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.58 | 15621674 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
10.04 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
10.04 | 11807958 17203775 11408345 16891317 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
10.04 | 17203775 11408345 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.51 | 19453300 |
MESH:D008545 |
Melanoma |
|
decitabine |
3.55 | 17785578 16505122 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
3.55 | 16827129 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
10.88 | 19513568 |
MESH:D008546 |
Melanoma, Experimental |
|
Cyclophosphamide |
10.88 | 16388313 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
3.06 | 17638057 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.82 | 16801185 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.50 | 15792986 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
3.63 | 16757204 18986760 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
12.49 | 17415656 |
MESH:D052016 |
Mucositis |
|
irinotecan |
12.49 | 17159606 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
3.35 | 18172295 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.52 | 16239165 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
3.38 | 16882708 19157545 18608210 19010910 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
5.71 | 19429709 15857846 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
5.71 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.02 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
8.26 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
8.26 | 16411023 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
6.10 | 18259882 |
MESH:D009362 |
Neoplasm Metastasis |
|
irinotecan |
6.10 | 18259882 |
MESH:D009369 |
Neoplasms |
|
Cyclophosphamide |
11.93 | 18854779 |
MESH:D009369 |
Neoplasms |
|
decitabine |
11.93 | 19116145 17925555 19470736 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
11.93 | 18239605 18600527 16928823 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
11.93 | 17405874 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.75 | 17289903 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.78 | 16899518 16636307 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.47 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
9.31 | 18481113 19348381 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
9.31 | 15640375 16889571 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
9.50 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
9.50 | 14600291 |
MESH:D009447 |
Neuroblastoma |
|
Cyclophosphamide |
16.33 | 15176712 16115947 8761367 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
16.33 | 15555623 |
MESH:D009447 |
Neuroblastoma |
|
irinotecan |
16.33 | 8761367 |
MESH:D009447 |
Neuroblastoma |
|
Topotecan |
16.33 | 15176712 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
2.87 | 18514411 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cyclophosphamide |
11.60 | 8761367 12837982 |
MESH:D017599 |
Neuroectodermal Tumors |
|
irinotecan |
11.60 | 8761367 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
3.44 | 16436463 |
MESH:D009503 |
Neutropenia |
|
Cyclophosphamide |
4.33 | 8291058 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.81 | 20558911 |
MESH:D009845 |
Oligospermia |
|
Cyclophosphamide |
4.73 | 16517039 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.11 | 15930896 |
MESH:D010051 |
Ovarian Neoplasms |
therapeutic |
|
| 15674352 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
11.36 | 19331143 19259094 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
11.36 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Mifepristone |
11.36 | 16525653 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
11.36 | 17393432 16525653 |
MESH:D010146 |
Pain |
|
Acetaminophen |
6.86 | 16870215 |
MESH:D010146 |
Pain |
|
Cyclophosphamide |
6.86 | 18093676 12161096 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cyclophosphamide |
8.78 | 11332152 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
8.78 | 19294695 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
8.78 | 16500647 16929163 19003803 15113037 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.28 | 12520081 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
5.19 | 17983394 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
5.19 | 17638057 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.57 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.22 | 12371664 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Cyclophosphamide |
3.80 | 21297632 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.21 | 11118676 11222880 11399792 11896295 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
4.74 | 17616702 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.89 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cyclophosphamide |
1.89 | 17136230 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
1.89 | 16888761 15897917 15749863 18437689 16868541 16729912 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
1.89 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
1.89 | 18626508 19082440 |
MESH:D011471 |
Prostatic Neoplasms |
|
methylselenic acid |
1.89 | 16205645 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.23 | 16882103 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Cyclophosphamide |
3.28 | 16636934 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
4.01 | 18286688 16160472 15538739 18722050 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.23 | 17922066 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.39 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.85 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
4.41 | 19155313 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.86 | 18045962 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
3.99 | 15625365 15675481 18313854 17710206 16767912 17203757 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
4.25 | 14601052 16326096 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.81 | 17846226 |
MESH:D012595 |
Scleroderma, Systemic |
|
Cyclophosphamide |
4.83 | 16636934 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
5.69 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.69 | 16192470 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.58 | 15625365 17203757 16767912 |
OMIM:102530 |
SPERMATOGENIC FAILURE 6 |
|
Cyclophosphamide |
5.53 | 16517039 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
4.30 | 15862959 16503802 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
3.51 | 19037991 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
3.51 | 16424979 17522103 19015929 19084572 18396642 17498489 17172411 16951190 15786421 18567086 |
MESH:D013274 |
Stomach Neoplasms |
|
irinotecan |
3.51 | 15723263 |
MESH:D015173 |
Supratentorial Neoplasms |
|
Cyclophosphamide |
5.08 | 12837982 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.93 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
7.43 | 17967635 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
7.43 | 16010429 17909728 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.72 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
3.99 | 16280240 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cyclophosphamide |
8.52 | 14692829 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
8.52 | 19087683 17616700 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
8.52 | 17653716 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.98 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
3.88 | 16803524 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
4.94 | 17785578 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.01 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.62 | 12125929 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.23 | 17334414 16364871 17678736 17638931 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.28 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.47 | 17120751 |